Breast Cancer Clinical Trial
Role of the Immune Environment in Response to Therapy in Breast Cancer
Summary
This is an observational case-control study of tissues collected from women with ER+HER2- breast cancers. The immune environments of these cancers will be compared to triple negative and HER2+ breast cancers. No randomization or changes to standard of care treatment will occur as part of the study.
View Eligibility Criteria
Eligibility Criteria
Inclusion criteria:
Women 18 years of age or older with non-metastatic breast cancer undergoing surgical resection in the University of Pennsylvania Health System.
Exclusion criteria:
Males Children Pregnant individuals
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
Submit
There is 1 Location for this study
See Locations Near You
Abramson Cancer Center
Philadelphia Pennsylvania, 19104, United States
Philadelphia Pennsylvania, 19104, United States
How clear is this clinincal trial information?